EMA-话题@MedSci

#EMA#

580篇内容 | 2451人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1317313, encodeId=1325131e31361, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=[重复]Crit Rev Oncol Hemat：结直肠癌肝转移后肝功受损，如何选择治疗？, objectType=article, longId=102459, objectId=07e7102459f9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=07e7102459f9, replyNumber=0, likeNumber=53, createdTime=2017-06-21, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=07e7102459f9, moduleTitle=[重复]Crit Rev Oncol Hemat：结直肠癌肝转移后肝功受损，如何选择治疗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=07e7102459f9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317312, encodeId=01b0131e3126b, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Crit Rev Oncol Hematol：结直肠癌肝转移后肝功受损，如何选择治疗？, objectType=article, longId=102387, objectId=761a10238ebb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=761a10238ebb, replyNumber=0, likeNumber=92, createdTime=2017-06-20, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=761a10238ebb, moduleTitle=Crit Rev Oncol Hematol：结直肠癌肝转移后肝功受损，如何选择治疗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=761a10238ebb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317311, encodeId=dab4131e3118a, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Pediatr Hemat Oncol：铂治疗后的听力损失在非脑照射儿童时期癌症存活者中是不可逆的, objectType=article, longId=102368, objectId=82f210236829, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=82f210236829, replyNumber=0, likeNumber=80, createdTime=2017-06-20, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=82f210236829, moduleTitle=Pediatr Hemat Oncol：铂治疗后的听力损失在非脑照射儿童时期癌症存活者中是不可逆的, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=82f210236829)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317310, encodeId=ef23131e310eb, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Br J Haematol：肺动脉高压风险或与使用这些药物有关, objectType=article, longId=102219, objectId=b9d1102219cf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b9d1102219cf, replyNumber=0, likeNumber=72, createdTime=2017-06-18, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b9d1102219cf, moduleTitle=Br J Haematol：肺动脉高压风险或与使用这些药物有关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b9d1102219cf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317309, encodeId=737f131e3091a, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Am J Hematol:依维莫司治疗复发或难治性惰性淋巴瘤疗效如何, objectType=article, longId=102217, objectId=d00710221e80, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d00710221e80, replyNumber=0, likeNumber=77, createdTime=2017-06-18, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d00710221e80, moduleTitle=Am J Hematol:依维莫司治疗复发或难治性惰性淋巴瘤疗效如何, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d00710221e80)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317308, encodeId=cb15131e308af, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Am J Hematol:新确诊BCR-ABL阳性ALL 基于伊马替尼化疗的疗效, objectType=article, longId=102215, objectId=a7811022158b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a7811022158b, replyNumber=0, likeNumber=56, createdTime=2017-06-18, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a7811022158b, moduleTitle=Am J Hematol:新确诊BCR-ABL阳性ALL 基于伊马替尼化疗的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a7811022158b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317307, encodeId=7880131e307f2, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Am J Hematol:癌症住院患者静脉血栓栓塞风险 KS预测工具是否有效, objectType=article, longId=102213, objectId=c8ac102213fe, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c8ac102213fe, replyNumber=0, likeNumber=60, createdTime=2017-06-18, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c8ac102213fe, moduleTitle=Am J Hematol:癌症住院患者静脉血栓栓塞风险 KS预测工具是否有效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c8ac102213fe)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317306, encodeId=922f131e306e5, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Am J Hematol：去甲基化药物治疗MDS：完全细胞遗传学响应对结局的影响, objectType=article, longId=102210, objectId=e9a410221037, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e9a410221037, replyNumber=0, likeNumber=58, createdTime=2017-06-18, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e9a410221037, moduleTitle=Am J Hematol：去甲基化药物治疗MDS：完全细胞遗传学响应对结局的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e9a410221037)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317305, encodeId=df89131e30581, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Haematologica：细胞外囊泡能挽救白血病细胞的自发性或药物诱导的凋亡, objectType=article, longId=102064, objectId=82ec10206461, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=82ec10206461, replyNumber=0, likeNumber=62, createdTime=2017-06-17, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=82ec10206461, moduleTitle=Haematologica：细胞外囊泡能挽救白血病细胞的自发性或药物诱导的凋亡, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=82ec10206461)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317304, encodeId=02c6131e3048d, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Haematologica：贫血的诊断不应只根据血红蛋白浓度，还应结合血浆容量, objectType=article, longId=101772, objectId=4e66101e7221, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4e66101e7221, replyNumber=0, likeNumber=83, createdTime=2017-06-15, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4e66101e7221, moduleTitle=Haematologica：贫血的诊断不应只根据血红蛋白浓度，还应结合血浆容量, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4e66101e7221)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317303, encodeId=ca9e131e303d1, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=JCO：晚期乳腺癌的患者的治疗--氟维司群+Abemaciclib，有效且安全（MONARCH 2研究）, objectType=article, longId=101534, objectId=2bbe101534d6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2bbe101534d6, replyNumber=0, likeNumber=62, createdTime=2017-06-12, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2bbe101534d6, moduleTitle=JCO：晚期乳腺癌的患者的治疗--氟维司群+Abemaciclib，有效且安全（MONARCH 2研究）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2bbe101534d6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317302, encodeId=2b6f131e30276, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Haematologica：STAT3和STAT5靶向结合--克服慢性粒细胞白血病耐药的新方法, objectType=article, longId=101532, objectId=6e9d1015327d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6e9d1015327d, replyNumber=0, likeNumber=61, createdTime=2017-06-12, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6e9d1015327d, moduleTitle=Haematologica：STAT3和STAT5靶向结合--克服慢性粒细胞白血病耐药的新方法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6e9d1015327d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317301, encodeId=75d7131e3010a, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Lancet Haematol：Janus激酶-2抑制剂fedratinib在先前用ruxolitinib治疗的骨髓纤维化患者中的治疗效果, objectType=article, longId=101497, objectId=250110149ec1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=250110149ec1, replyNumber=0, likeNumber=90, createdTime=2017-06-12, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=250110149ec1, moduleTitle=Lancet Haematol：Janus激酶-2抑制剂fedratinib在先前用ruxolitinib治疗的骨髓纤维化患者中的治疗效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=250110149ec1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317300, encodeId=729d131e300e1, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Haematologica：经伊马替尼治疗的慢性粒细胞白血病患者第二个原发恶性肿瘤发病率及相关死亡率如何？, objectType=article, longId=100782, objectId=e408100e82fa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e408100e82fa, replyNumber=0, likeNumber=82, createdTime=2017-06-07, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e408100e82fa, moduleTitle=Haematologica：经伊马替尼治疗的慢性粒细胞白血病患者第二个原发恶性肿瘤发病率及相关死亡率如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e408100e82fa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317299, encodeId=b28c131e299d9, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Am J Hematol：BCL2突变是否导致利妥昔单抗治疗的滤泡性淋巴瘤患者预后不良？, objectType=article, longId=100766, objectId=a2e7100e6654, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a2e7100e6654, replyNumber=0, likeNumber=85, createdTime=2017-06-07, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a2e7100e6654, moduleTitle=Am J Hematol：BCL2突变是否导致利妥昔单抗治疗的滤泡性淋巴瘤患者预后不良？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a2e7100e6654)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317298, encodeId=ac2d131e29839, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Am J Hematol：惰性非霍奇金淋巴瘤：LR-CD方案效果如何？, objectType=article, longId=100762, objectId=c0dc100e6241, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c0dc100e6241, replyNumber=0, likeNumber=60, createdTime=2017-06-07, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c0dc100e6241, moduleTitle=Am J Hematol：惰性非霍奇金淋巴瘤：LR-CD方案效果如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c0dc100e6241)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317297, encodeId=3305131e297bf, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Lancet Haematol：不明原因静脉血栓栓塞：利伐沙班or华法林？, objectType=article, longId=100761, objectId=dea9100e61c6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dea9100e61c6, replyNumber=0, likeNumber=71, createdTime=2017-06-07, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dea9100e61c6, moduleTitle=Lancet Haematol：不明原因静脉血栓栓塞：利伐沙班or华法林？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dea9100e61c6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317296, encodeId=34dc131e296e2, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Haematologica：脾切除术后心血管事件和肺动脉高压的风险如何？, objectType=article, longId=100660, objectId=11e5100660f1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=11e5100660f1, replyNumber=0, likeNumber=71, createdTime=2017-06-05, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=11e5100660f1, moduleTitle=Haematologica：脾切除术后心血管事件和肺动脉高压的风险如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=11e5100660f1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317295, encodeId=f8bd131e295a6, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Haematologica：血管性血友病患者关节出血的长期影响如何？, objectType=article, longId=100659, objectId=321c100659cf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=321c100659cf, replyNumber=0, likeNumber=65, createdTime=2017-06-05, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=321c100659cf, moduleTitle=Haematologica：血管性血友病患者关节出血的长期影响如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=321c100659cf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317294, encodeId=7fc2131e2945b, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Haematologica：较短的白细胞端粒长度与较高的感染风险相关！, objectType=article, longId=100124, objectId=0cdd1001244c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0cdd1001244c, replyNumber=0, likeNumber=56, createdTime=2017-05-31, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0cdd1001244c, moduleTitle=Haematologica：较短的白细胞端粒长度与较高的感染风险相关！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0cdd1001244c)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

EMA

2020-05-29

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

[重复]Crit Rev Oncol Hemat：结直肠癌肝转移后肝功受损，如何选择治疗？

2017-06-21

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Crit Rev Oncol Hematol：结直肠癌肝转移后肝功受损，如何选择治疗？

2017-06-20

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Pediatr Hemat Oncol：铂治疗后的听力损失在非脑照射儿童时期癌症存活者中是不可逆的

2017-06-20

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Br J Haematol：肺动脉高压风险或与使用这些药物有关

2017-06-18

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Am J Hematol:依维莫司治疗复发或难治性惰性淋巴瘤疗效如何

2017-06-18

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Am J Hematol:新确诊BCR-ABL阳性ALL 基于伊马替尼化疗的疗效

2017-06-18

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Am J Hematol:癌症住院患者静脉血栓栓塞风险 KS预测工具是否有效

2017-06-18

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Am J Hematol：去甲基化药物治疗MDS：完全细胞遗传学响应对结局的影响

2017-06-18

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Haematologica：细胞外囊泡能挽救白血病细胞的自发性或药物诱导的凋亡

2017-06-17

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Haematologica：贫血的诊断不应只根据血红蛋白浓度，还应结合血浆容量

2017-06-15

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

JCO：晚期乳腺癌的患者的治疗--氟维司群+Abemaciclib，有效且安全（MONARCH 2研究）

2017-06-12

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Haematologica：STAT3和STAT5靶向结合--克服慢性粒细胞白血病耐药的新方法

2017-06-12

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Lancet Haematol：Janus激酶-2抑制剂fedratinib在先前用ruxolitinib治疗的骨髓纤维化患者中的治疗效果

2017-06-12

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Haematologica：经伊马替尼治疗的慢性粒细胞白血病患者第二个原发恶性肿瘤发病率及相关死亡率如何？

2017-06-07

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Am J Hematol：BCL2突变是否导致利妥昔单抗治疗的滤泡性淋巴瘤患者预后不良？

2017-06-07

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Am J Hematol：惰性非霍奇金淋巴瘤：LR-CD方案效果如何？

2017-06-07

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Lancet Haematol：不明原因静脉血栓栓塞：利伐沙班or华法林？

2017-06-07

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Haematologica：脾切除术后心血管事件和肺动脉高压的风险如何？

2017-06-05

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Haematologica：血管性血友病患者关节出血的长期影响如何？

2017-06-05

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Haematologica：较短的白细胞端粒长度与较高的感染风险相关！

2017-05-31

科室
- - 订阅+
  - 更多科室
工具
服务